SG Americas Securities’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16,568
| Closed | -$56K | – | 3159 |
|
|
2025
Q1 | $56K | Sell |
16,568
-6,476
| -28% | -$21.9K | ﹤0.01% | 2833 |
|
|
2024
Q4 | $131K | Buy |
23,044
+10,704
| +87% | +$60.9K | ﹤0.01% | 2252 |
|
|
2024
Q3 | $72K | Buy |
12,340
+1,560
| +14% | +$9.1K | ﹤0.01% | 2806 |
|
|
2024
Q2 | $85K | Buy |
+10,780
| New | +$85K | ﹤0.01% | 2257 |
|
|
2021
Q2 | – | Sell |
-126,600
| Closed | -$596K | – | 2885 |
|
|
2021
Q1 | $596K | Buy |
+126,600
| New | +$596K | ﹤0.01% | 1718 |
|
|
2020
Q4 | – | Sell |
-9,388
| Closed | -$100K | – | 2915 |
|
|
2020
Q3 | $100K | Sell |
9,388
-13,728
| -59% | -$146K | ﹤0.01% | 2062 |
|
|
2020
Q2 | $292K | Buy |
23,116
+2,333
| +11% | +$29.5K | ﹤0.01% | 2174 |
|
|
2020
Q1 | $190K | Buy |
+20,783
| New | +$190K | ﹤0.01% | 2134 |
|
|
2019
Q3 | – | Sell |
-54,741
| Closed | -$1.49M | – | 2666 |
|
|
2019
Q2 | $1.49M | Sell |
54,741
-12,638
| -19% | -$344K | 0.01% | 1089 |
|
|
2019
Q1 | $1.29M | Buy |
67,379
+6,204
| +10% | +$119K | 0.01% | 1001 |
|
|
2018
Q4 | $575K | Buy |
61,175
+49,478
| +423% | +$465K | 0.01% | 1512 |
|
|
2018
Q3 | $221K | Sell |
11,697
-21,585
| -65% | -$408K | ﹤0.01% | 2198 |
|
|
2018
Q2 | $650K | Buy |
+33,282
| New | +$650K | 0.01% | 1595 |
|
|
2018
Q1 | – | Sell |
-7,117
| Closed | -$118K | – | 2911 |
|
|
2017
Q4 | $118K | Sell |
7,117
-20,912
| -75% | -$347K | ﹤0.01% | 2328 |
|
|
2017
Q3 | $577K | Buy |
+28,029
| New | +$577K | 0.01% | 1504 |
|
|
2016
Q4 | – | Sell |
-11,195
| Closed | -$134K | – | 2969 |
|
|
2016
Q3 | $134K | Buy |
+11,195
| New | +$134K | ﹤0.01% | 2506 |
|